FTC asks for additional info on Roche's proposed Illumina buy; Covidien reportedly buying Israeli firm for $350M;

@FierceMedDev: Health Care Prosecution Losses Mar U.S. Marketing Probe, via BloombergNews. Story | | Follow @FierceMedDev

> Roche ($RHHBY) has received a request for additional information from the Federal Trade Commission related to its proposed acquisition of Illumina ($ILMN). Roche release

> Covidien ($COV) is reportedly buying Israel's Super-Dimension, which develops devices to diagnose pulmonary diseases, for $350 million. Item

> OptiMedica has nearly tripled its operation size with its new 55,000-square-foot facility in Sunnyvale, CA. It will serve as the base for the company's worldwide commercial launch of the Catalys precision laser system for cataract surgery. OptiMedica release

> Consumer Reports is trying to persuade the American public to question the way devices are approved by the FDA. News

> Doctors are finding that iPads are helping them be more efficient at ordering tests and procedures for their patients. Report

And Finally... A worry in any surgical theater is the air supply not being as sterile as possible. But IMEX's Arc Sterile is helping out by introducing purified, surgical quality air to just about any environment. Item
 

Suggested Articles

AI-based drug molecule designer XtalPi has secured a mammoth funding round totaling $318.8 million, from global banking and tech investors.

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.